Our goal is:

  • to serve as a resource for biotech and pharmaceutical industry
  • to carry out pre-clinical and clinical drug development programs
  • to assist basic science departments to bring drug candidates into clinical development
  • to support clinicians/ scientists in the planning, conduct, bioanalytics, pharmacokinetic and statistic analysis, reporting/ publishing

iC42 was created to take leadership in the evaluation of pharmacokinetics, drug metabolism and the development of clinical diagnostic tools. Our team carries out research and development projects including molecular marker discovery, translational research, strategy development and the identification of molecular mechanisms.

We can help you with projects in metabolomics, molecular markers, custom methodologies and pediatric pharmacokinetics. We encourage and seek out successful collaborations and strategic partnerships. Currently, iC42 collaborates with more than 40 entities including academic groups, biotech and pharmaceutical companies all over the world.

Comments are closed.